Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells

• DOI: 10.1007/s00125-020-05276-4
• Publication Date: 2020-10-07T23:04:53Z
• Authors: Matthew B. Johnson; Kashyap A. Patel; Elisa De Franco; William Hagopian; Michael Killian; Timothy J. McDonald; Timothy I. M. Tree; Clara Domingo-Vila; Michelle Hudson; Suzanne Hammersley; Rebecca Dobbs; ; Sian Ellard; Sarah E. Flanagan; Andrew T. Hattersley; Richard A. Oram
• Keywords: Male; 571; C-Peptide; Neonatal diabetes; Infant, Newborn; Infant; Autoimmunity; Genetic risk score; Article; 3. Good health; Wessex Classification Subject Headings::Endocrinology::Diabetes; 03 medical and health sciences; Type 1 diabetes; Diabetes Mellitus, Type 1; 0302 clinical medicine; Insulin-Secreting Cells; Humans; Female; Genetic Testing; Biomarkers

Abstract Aims/hypothesis Diabetes diagnosed at <6 months of age is usually monogenic. However, 10–15% of affected infants do not have a pathogenic variant in one of the 26 known neonatal diabetes genes. We characterised infants diagnosed at <6 months of age without a pathogenic variant to assess whether polygenic type 1 diabetes could arise at early ages.

Methods We studied 166 infants diagnosed with type 1 diabetes at <6 months of age in whom pathogenic variants in all 26 known genes had been excluded and compared them with infants with monogenic neonatal diabetes (n = 164) or children with type 1 diabetes diagnosed at 6–24 months of age (n = 152). We assessed the type 1 diabetes genetic risk score (T1D-GRS), islet autoantibodies, C-peptide and clinical features.

Results We found an excess of infants with high T1D-GRS: 38% (63/166) had a T1D-GRS >95th centile of healthy individuals, whereas 5% (8/166) would be expected if all were monogenic (p < 0.0001). Individuals with a high T1D-GRS had a similar rate of autoantibody positivity to that seen in individuals with type 1 diabetes diagnosed at 6–24 months of age (41% vs 58%, p = 0.2), and had markedly reduced C-peptide levels (median <3 pmol/l within 1 year of diagnosis), reflecting rapid loss of insulin secretion. These individuals also had reduced birthweights (median z score −0.89), which were lowest in those diagnosed with type 1 diabetes at <3 months of age (median z score −1.98).

Conclusions/interpretation We provide strong evidence that type 1 diabetes can present before the age of 6 months based on individuals with this extremely early-onset diabetes subtype having the classic features of childhood type 1 diabetes: high genetic risk, autoimmunity and rapid beta cell loss. The early-onset association with reduced birthweight raises the possibility that for some individuals there was reduced insulin secretion in utero. Comprehensive genetic testing for all neonatal diabetes genes remains essential for all individuals diagnosed with diabetes at <6 months of age.